




Searching News Database: Javelin Pharmaceuticals
HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
HSMN NewsFeed - 14 Jul 2010
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
HSMN NewsFeed - 3 Jun 2010
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
HSMN NewsFeed - 19 Apr 2010
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
HSMN NewsFeed - 12 Apr 2010
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
HSMN NewsFeed - 12 Apr 2010
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
HSMN NewsFeed - 2 Feb 2010
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
HSMN NewsFeed - 5 Jun 2008
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director
HSMN NewsFeed - 16 Apr 2008
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development
HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
HSMN NewsFeed - 22 May 2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
HSMN NewsFeed - 30 Jan 2007
Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine
Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine
HSMN NewsFeed - 24 Apr 2006
Stephen Tulipano Joins Javelin Pharmaceuticals as Chief Financial Officer
Stephen Tulipano Joins Javelin Pharmaceuticals as Chief Financial Officer
HSMN NewsFeed - 23 Jan 2006
Preliminary Phase IIb Study Shows Dyloject(TM) Relieves Postoperative Pain Faster Than Ketorolac
Preliminary Phase IIb Study Shows Dyloject(TM) Relieves Postoperative Pain Faster Than Ketorolac
Additional items found! 3

Members Archive contains
3 additional stories matching:
Javelin Pharmaceuticals
(Password required)
Javelin Pharmaceuticals
(Password required)